Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 1;35(4):344-351.
doi: 10.1097/GCO.0000000000000885. Epub 2023 May 26.

Take it or leave it: oophorectomy at the time of benign hysterectomy

Affiliations
Review

Take it or leave it: oophorectomy at the time of benign hysterectomy

Hilary R Haber et al. Curr Opin Obstet Gynecol. .

Abstract

Purpose of review: Previous modeling data suggest ovarian conservation up to age 65 for women without adnexal disease and at average risk of ovarian cancer because of an increase in mortality associated with ovarian removal. Recent modeling data challenges this practice. This review of recent literature will update providers regarding consideration for oophorectomy at time of benign hysterectomy.

Recent findings: Oophorectomy at time of hysterectomy for women less than 50 years with estrogen supplementation and greater than 50 years without estrogen supplementation is not associated with increased mortality.

Summary: Although not associated with increased mortality, the decision to remove the ovaries at time of hysterectomy in women older than 50 years is nuanced and requires careful shared decision-making, considering unique patient factors.

PubMed Disclaimer

References

    1. QuickStats: percentage of women aged ≥50 years who have had a hysterectomy, by race/ethnicity and year - National Health Interview Survey, United States, 2008 and 2018. MMWR Morb Mortal Wkly Rep 2019; 68:935.
    1. Mikhail E, Salemi JL, Mogos MF, et al. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998–2011. Am J Obstet Gynecol 2015; 213: 713.e1-13.
    1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321–333.
    1. Novetsky AP, Boyd LR, Curtin JP. Trends in bilateral oophorectomy at the time of hysterectomy for benign disease. Obstet Gynecol 2011; 118:1280–1286.
    1. Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005; 106:219–226.